4.8 Article

Allosteric modulation of AMPA receptors counteracts Tau-related excitotoxic synaptic signaling and memory deficits in stress- and Aβ-evoked hippocampal pathology

Journal

MOLECULAR PSYCHIATRY
Volume 26, Issue 10, Pages 5899-5911

Publisher

SPRINGERNATURE
DOI: 10.1038/s41380-020-0794-5

Keywords

-

Funding

  1. Institut de Recherches Internationales Servier (France)
  2. Programa de Atividades Conjuntas (PAC), through MEDPERSYST project - Portugal 2020 Programme Fund (FEDER) [POCI-01-0145-FEDER-016428]
  3. European Regional Development Fund COMPETE [FCOMP-01-0124-FEDER-037298]
  4. Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development [NORTE-01-0145-FEDER-000013]

Ask authors/readers for more resources

Despite progress in understanding AD neuropathology, there is no effective treatment for the memory deficits caused by A beta and Tau protein accumulation. However, positive allosteric modulation of AMPA receptors shows promise in restoring memory and synaptic signaling in non-transgenic animal models.
Despite considerable progress in the understanding of its neuropathology, Alzheimer's disease (AD) remains a complex disorder with no effective treatment that counteracts the memory deficits and the underlying synaptic malfunction triggered by the accumulation of amyloid beta (A beta) and Tau protein. Mounting evidence supports a precipitating role for chronic environmental stress and glutamatergic excitotoxicity in AD, suggesting that targeting of glutamate receptor signaling may be a promising approach against both stress and AD pathologies. In light of the limited cognitive benefit of the direct antagonism of NMDA receptors in AD, we here focus on an alternative way to modify glutamatergic signaling through positive allosteric modulation of AMPA receptors, by the use of a PAM-AMPA compound. Using non-transgenic animal model of A beta oligomer injection as well as the combined stress and A beta i.c.v. infusion, we demonstrate that positive allosteric modulation of AMPA receptors by PAM-AMPA treatment reverted memory, but not mood, deficits. Furthermore, PAM-AMPA treatment reverted stress/A beta-driven synaptic missorting of Tau and associated Fyn/GluN2B-driven excitotoxic synaptic signaling accompanied by recovery of neurotransmitter levels in the hippocampus. Our findings suggest that positive allosteric modulation of AMPA receptors restores synaptic integrity and cognitive performance in stress- and A beta-evoked hippocampal pathology. As the prevalence of AD is increasing at an alarming rate, novel therapeutic targeting of glutamatergic signaling should be further explored against the early stages of AD synaptic malfunction with the goal of attenuating further synaptic damage before it becomes irreversible.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available